The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus.
Presence of femoral atheromatic plaques, an emerging cardiovascular disease (CVD) biomarker additional to carotid plaques, is poorly investigated in conditions associating with accelerated atherosclerosis such as Rheumatoid Arthritis (RA), Human Immunodeficiency Virus (HIV) infection and Type 2 Diab...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4521696?pdf=render |
| _version_ | 1818034524336947200 |
|---|---|
| author | Athanasios D Protogerou Jaap Fransen Evangelia Zampeli Antonis A Argyris Evagelia Aissopou Aikaterini Arida George D Konstantonis Nikos Tentolouris Konstantinos Makrilakis Mina Psichogiou George Daikos George D Kitas Petros P Sfikakis |
| author_facet | Athanasios D Protogerou Jaap Fransen Evangelia Zampeli Antonis A Argyris Evagelia Aissopou Aikaterini Arida George D Konstantonis Nikos Tentolouris Konstantinos Makrilakis Mina Psichogiou George Daikos George D Kitas Petros P Sfikakis |
| author_sort | Athanasios D Protogerou |
| collection | DOAJ |
| description | Presence of femoral atheromatic plaques, an emerging cardiovascular disease (CVD) biomarker additional to carotid plaques, is poorly investigated in conditions associating with accelerated atherosclerosis such as Rheumatoid Arthritis (RA), Human Immunodeficiency Virus (HIV) infection and Type 2 Diabetes Mellitus (T2DM).To assess the frequency of femoral/carotid subclinical atheromatosis phenotypes in RA, HIV and T2DM and search for each disease-specific probability of either femoral and/or carotid subclinical atheromatosis, we examined by ultrasound a single-center cohort of CVD-free individuals comprised of consecutive non-diabetic patients with RA (n=226) and HIV (n=133), T2DM patients (n=109) and non-diabetic individuals with suspected/known hypertension (n=494) who served as reference group.Subclinical atheromatosis--defined as local plaque presence in at least on arterial bed--was diagnosed in 50% of the overall population. Among them, femoral plaques only were found in 25% of either RA or HIV patients, as well as in 16% of T2DM patients and 35% of reference subjects. After adjusting for all classical CVD risk factors, RA and HIV patients had comparable probability to reference group of having femoral plaques, but higher probability (1.75; 1.17-2.63 (odds ratio; 95% confidence intervals), 2.04; 1.14-3.64, respectively) of having carotid plaques, whereas T2DM patients had higher probability to have femoral and carotid plaques, albeit, due to their pronounced dyslipidemic profile.RA and HIV accelerate predominantly carotid than femoral. A "two windows" carotid/femoral, rather than carotid alone ultrasound, screening improves substantially subclinical atheromatosis detection in patients at high CVD risk. |
| first_indexed | 2024-12-10T06:40:32Z |
| format | Article |
| id | doaj.art-bb69147cb5a94664ba1fd2e286c53084 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T06:40:32Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-bb69147cb5a94664ba1fd2e286c530842022-12-22T01:58:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013230710.1371/journal.pone.0132307The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus.Athanasios D ProtogerouJaap FransenEvangelia ZampeliAntonis A ArgyrisEvagelia AissopouAikaterini AridaGeorge D KonstantonisNikos TentolourisKonstantinos MakrilakisMina PsichogiouGeorge DaikosGeorge D KitasPetros P SfikakisPresence of femoral atheromatic plaques, an emerging cardiovascular disease (CVD) biomarker additional to carotid plaques, is poorly investigated in conditions associating with accelerated atherosclerosis such as Rheumatoid Arthritis (RA), Human Immunodeficiency Virus (HIV) infection and Type 2 Diabetes Mellitus (T2DM).To assess the frequency of femoral/carotid subclinical atheromatosis phenotypes in RA, HIV and T2DM and search for each disease-specific probability of either femoral and/or carotid subclinical atheromatosis, we examined by ultrasound a single-center cohort of CVD-free individuals comprised of consecutive non-diabetic patients with RA (n=226) and HIV (n=133), T2DM patients (n=109) and non-diabetic individuals with suspected/known hypertension (n=494) who served as reference group.Subclinical atheromatosis--defined as local plaque presence in at least on arterial bed--was diagnosed in 50% of the overall population. Among them, femoral plaques only were found in 25% of either RA or HIV patients, as well as in 16% of T2DM patients and 35% of reference subjects. After adjusting for all classical CVD risk factors, RA and HIV patients had comparable probability to reference group of having femoral plaques, but higher probability (1.75; 1.17-2.63 (odds ratio; 95% confidence intervals), 2.04; 1.14-3.64, respectively) of having carotid plaques, whereas T2DM patients had higher probability to have femoral and carotid plaques, albeit, due to their pronounced dyslipidemic profile.RA and HIV accelerate predominantly carotid than femoral. A "two windows" carotid/femoral, rather than carotid alone ultrasound, screening improves substantially subclinical atheromatosis detection in patients at high CVD risk.http://europepmc.org/articles/PMC4521696?pdf=render |
| spellingShingle | Athanasios D Protogerou Jaap Fransen Evangelia Zampeli Antonis A Argyris Evagelia Aissopou Aikaterini Arida George D Konstantonis Nikos Tentolouris Konstantinos Makrilakis Mina Psichogiou George Daikos George D Kitas Petros P Sfikakis The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. PLoS ONE |
| title | The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. |
| title_full | The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. |
| title_fullStr | The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. |
| title_full_unstemmed | The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. |
| title_short | The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. |
| title_sort | additive value of femoral ultrasound for subclinical atherosclerosis assessment in a single center cohort of 962 adults including high risk patients with rheumatoid arthritis human immunodeficiency virus infection and type 2 diabetes mellitus |
| url | http://europepmc.org/articles/PMC4521696?pdf=render |
| work_keys_str_mv | AT athanasiosdprotogerou theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT jaapfransen theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT evangeliazampeli theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT antonisaargyris theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT evageliaaissopou theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT aikateriniarida theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedkonstantonis theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT nikostentolouris theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT konstantinosmakrilakis theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT minapsichogiou theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedaikos theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedkitas theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT petrospsfikakis theadditivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT athanasiosdprotogerou additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT jaapfransen additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT evangeliazampeli additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT antonisaargyris additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT evageliaaissopou additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT aikateriniarida additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedkonstantonis additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT nikostentolouris additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT konstantinosmakrilakis additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT minapsichogiou additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedaikos additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT georgedkitas additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus AT petrospsfikakis additivevalueoffemoralultrasoundforsubclinicalatherosclerosisassessmentinasinglecentercohortof962adultsincludinghighriskpatientswithrheumatoidarthritishumanimmunodeficiencyvirusinfectionandtype2diabetesmellitus |